Skip to main content
. 2023 May 15;12(13):14317–14326. doi: 10.1002/cam4.6108

FIGURE 2.

FIGURE 2

Mutations detected by WES in tissues at baseline from 16 patients with locally advanced or metastatic NSCLC. The rows at the top show TMB level, clinical responses, PD‐L1 expression level (including 22C3 and E1L3N), gender, age, smoking history, stage and pathologic type. The rows at the middle indicate mutated genes ordered based on decreasing prevalence. NSCLC, non‐small cell lung cancer; PD, progression disease; PD‐L1, programmed cell death ligand 1; PR, partial response; SD, stable disease; TMB, tumor mutational burden; WES, whole‐exome sequencing.